Sotac Pharmaceuticals' Stock Reaches All-Time High Amid Strong Performance in Pharmaceutical Industry
Sotac Pharmaceuticals, a microcap pharmaceutical company, has reached an all-time high stock price of Rs.155 on March 8th, 2024. Despite underperforming the sector today, the company's moving averages are higher, indicating a positive trend. With a 'Hold' stock call, Sotac Pharmaceuticals has shown promising growth and potential for future returns.
Sotac Pharmaceuticals, a microcap pharmaceutical company, has recently seen a surge in its stock price, reaching an all-time high of Rs.155 on March 8th, 2024. This comes as a result of the company's strong performance in the pharmaceutical and drugs industry.
According to MarketsMOJO, a leading financial analysis platform, the stock call for Sotac Pharmaceuticals is currently 'Hold'. This indicates that while the company's stock price has reached a new high, it may not be the best time to buy or sell the stock.
In terms of performance, Sotac Pharmaceuticals has underperformed the sector by -0.28% today. However, the company's moving averages are higher than the 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price.
It is worth noting that Sotac Pharmaceuticals is a microcap company, meaning it has a market capitalization of less than $300 million. Despite its small size, the company has shown promising growth in the past year, outperforming the Sensex by NA%.
Overall, Sotac Pharmaceuticals' recent surge in stock price is a reflection of its strong performance in the pharmaceutical industry. While the stock call is currently 'Hold', investors may want to keep an eye on this microcap company as it continues to grow and potentially offer promising returns in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
